DKK1 and Alzheimer disease: Decreased levels of Wnt as shown by the increase in Dkk-1, which is an antagonist of Wnt/β-catenin, were significantly associated with progressively higher CDR-SB scores (indicating more impairment) among patients with AD but not among patients with MCI.